vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and SES AI Corp (SES). Click either name above to swap in a different company.

BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $4.6M, roughly 1.8× SES AI Corp).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

SES S.A. is a Luxembourgish communications satellite operator supplying video and data connectivity worldwide to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions.

BHST vs SES — Head-to-Head

Bigger by revenue
BHST
BHST
1.8× larger
BHST
$8.4M
$4.6M
SES

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BHST
BHST
SES
SES
Revenue
$8.4M
$4.6M
Net Profit
$-17.0M
Gross Margin
60.3%
11.3%
Operating Margin
-387.7%
Net Margin
-373.5%
Revenue YoY
Net Profit YoY
50.7%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
SES
SES
Q4 25
$4.6M
Q3 25
$8.4M
$7.1M
Q2 25
$8.1M
$3.5M
Q1 25
$7.7M
$5.8M
Q3 24
$6.5M
Q2 24
$6.0M
Net Profit
BHST
BHST
SES
SES
Q4 25
$-17.0M
Q3 25
$-20.9M
Q2 25
$-22.7M
Q1 25
$-12.4M
Q3 24
Q2 24
Gross Margin
BHST
BHST
SES
SES
Q4 25
11.3%
Q3 25
60.3%
51.1%
Q2 25
60.0%
73.7%
Q1 25
58.2%
78.7%
Q3 24
Q2 24
Operating Margin
BHST
BHST
SES
SES
Q4 25
-387.7%
Q3 25
-262.0%
Q2 25
-652.3%
Q1 25
-401.7%
Q3 24
Q2 24
Net Margin
BHST
BHST
SES
SES
Q4 25
-373.5%
Q3 25
-293.9%
Q2 25
-642.2%
Q1 25
-214.6%
Q3 24
Q2 24
EPS (diluted)
BHST
BHST
SES
SES
Q4 25
$-0.05
Q3 25
$-0.06
Q2 25
$-0.07
Q1 25
$-0.04
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
SES
SES
Cash + ST InvestmentsLiquidity on hand
$29.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$214.8M
Total Assets
$272.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
SES
SES
Q4 25
$29.5M
Q3 25
$35.3M
Q2 25
$11.8M
Q1 25
$56.1M
Q3 24
Q2 24
Stockholders' Equity
BHST
BHST
SES
SES
Q4 25
$214.8M
Q3 25
$228.2M
Q2 25
$249.2M
Q1 25
$269.9M
Q3 24
Q2 24
Total Assets
BHST
BHST
SES
SES
Q4 25
$272.6M
Q3 25
$288.8M
Q2 25
$290.5M
Q1 25
$306.0M
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
SES
SES
Operating Cash FlowLast quarter
$-10.4M
Free Cash FlowOCF − Capex
$-11.1M
FCF MarginFCF / Revenue
-243.7%
Capex IntensityCapex / Revenue
15.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-61.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
SES
SES
Q4 25
$-10.4M
Q3 25
$-14.3M
Q2 25
$-10.8M
Q1 25
$-22.8M
Q3 24
Q2 24
Free Cash Flow
BHST
BHST
SES
SES
Q4 25
$-11.1M
Q3 25
$-14.7M
Q2 25
$-11.6M
Q1 25
$-23.7M
Q3 24
Q2 24
FCF Margin
BHST
BHST
SES
SES
Q4 25
-243.7%
Q3 25
-206.9%
Q2 25
-329.6%
Q1 25
-410.0%
Q3 24
Q2 24
Capex Intensity
BHST
BHST
SES
SES
Q4 25
15.6%
Q3 25
6.0%
Q2 25
22.8%
Q1 25
15.8%
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons